ArcelorMittal's South Africa says its Saldanha operations lost their competitive cost advantage to compete in the export market, \"mainly due to raw material and regulated prices\"

On Thursday, Glenmark Pharmaceuticals reported Rs 104.7 crore loss in December quarter on sharp decline in US sales. The company had reported a net profit of Rs 477.10 crore in the corresponding quarter of the previous year.

Top pharma companies - Driven by inorganic growth opportunities - are also learning to live with more debt.

Indian officials say they have proposed an oil-for-drugs barter plan with cash-strapped Venezuela to recoup millions of dollars in payments owed to some of India's largest pharmaceutical companies.

These are tricky times for Indian pharma and they can hardly afford any lapse in their production facilities when the US drug regulator (the US Food and Drug Administration) inspections happen.

Business Today awards India's Best CEOs for 2014, celebrating their success in various segments of the corporate world.

Under Anand Mahindra's leadership, M&M is scaling up its existing businesses and also betting big on new ones.

Pankaj R. Patel says the best advice got helped us address the growth aspirations of our people and maximise their talents

Companies with revenues between Rs 1,000 crore and Rs 2,000 crore that grew the fastest in 2007.